Nisa Investment Advisors’s Gossamer Bio GOSS Stock Holding History

Nisa Investment Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$310	Hold	24	–	–	﹤0.01%	3011
2026 Q1	$619	Sell	24 -1	-4%	-$126	﹤0.01%	2832
2025 Q4	$6.24K	Buy	+25	New	+$5.71K	﹤0.01%	2398
2022 Q4	–	Sell	-1	Closed	-$1K	–	2626
2022 Q3	$1K	Buy	+1	New	+$993	﹤0.01%	2431
2022 Q2	–	Sell	-880	Closed	-$611K	–	2422
2022 Q1	$611K	Buy	880 +502	+133%	+$387K	﹤0.01%	1014
2021 Q4	$290K	Buy	378 +294	+350%	+$279K	﹤0.01%	1158
2021 Q3	$85K	Sell	84 -438	-84%	-$323K	﹤0.01%	1768
2021 Q2	$339K	Buy	+522	New	+$362K	﹤0.01%	1243

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Nisa Investment Advisors's GOSS Position: Q2 2026 in Review

Nisa Investment Advisors held its Gossamer Bio (GOSS) position steady in Q2 2026 at 24 shares worth $310. The position accounts for ﹤0.01% of the portfolio, ranked #3011.

Nisa Investment Advisors first reported a position in GOSS in Q2 2021 and has held it in 8 quarters since. The position peaked at $611K in Q1 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Nisa Investment Advisors held 24 shares of Gossamer Bio worth $310 as of Q2 2026.
Nisa Investment Advisors left its Gossamer Bio share count unchanged in Q2 2026.
Gossamer Bio made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #3011 holding.
Nisa Investment Advisors first reported a position in Gossamer Bio in Q2 2021 and has held it in 8 quarters since.
Nisa Investment Advisors's Gossamer Bio position peaked at $611K in Q1 2022.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.